Article
Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients.
PloS one - 1 Jan 2008
Gross Eva, Busse Birgit, Riemenschneider Matthias, Neubauer Steffi, Seck Katharina, Klein Hanns-Georg, Kiechle Marion, Lordick Florian, Meindl Alfons
Abstract excerpt
BACKGROUND: Cancer patients carrying mutations in the dihydropyrimidine dehydrogenase gene (DPYD) have a high risk to experience severe drug-adverse effects following chemotherapy with fluoropyrimidine drugs such as 5-fluorouracil (5-FU) or capecitabine. The pretreatment detection of this impairm...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
